spacer
home > > winter 2001 > an introduction to transdermal drug delivery systems
PAY PER VIEW SERVICE

 

Dear guest!

article: An Introduction to Transdermal Drug Delivery Systems
format: Adobe Acrobat PDF file
cost: £

spacer

Industry Events

INTERPHEX 2020

15-17 July 2020, Javits Center NYC


More info >>

 
News and Press Releases

Sartorius Supports the Development of the First Vaccine Candidate Against the Novel Coronavirus to Enter Clinical Trials

SHANGHAI, China, March 25, 2020 / B3C newswire / -- Sartorius, a leading international partner of life science research and the biopharmaceutical industry, has supported CanSino Biologics Inc. (“CanSinoBIO”) and Maj. Gen. Chen Wei’s team at the Institute of Bioengineering at the Academy of Military Medical Sciences (“Institute of Bioengineering”) in China in their development of the first vaccine candidate against the novel coronavirus SARS-CoV-2 to enter clinical trials. CanSinoBIO and the Institute of Bioengineering used Sartorius’ BIOSTAT® STR single-use bioreactor system for the upstream preparation of the recombinant vaccine, thus ensuring the rapid linear amplification of the adenovirus vector (Ad5-nCoV) and ultimately saving time during development.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement